Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of fluvoxamine maleate tablets in healthy Chinese adults under fasted and fed conditions
ChiCTR2000029525Phase 4Not yet recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluvoxamine (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoints: AUC0-t, AUC0-inf and 6 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
fluvoxamine
Beyond the preview
Go deeper on ChiCTR2000029525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029525.